UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 804

Sortiert nach

Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update

Hepatology research, 2019-10, Vol.49 (10), p.1109-1113

2019

Volltextzugriff (PDF)

Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey

Hepatology (Baltimore, Md.), 2017-08, Vol.66 (2), p.510-517

2017

Volltextzugriff (PDF)

Letter: association of laboratory indexes and magnetic resonance elastography‐associated liver stiffness with complications and mortality—authors' reply

Alimentary pharmacology & therapeutics, 2022-03, Vol.55 (5), p.626-627

2022

Volltextzugriff (PDF)

Letter: predictive role of magnetic resonance elastography in chronic liver disease—still a long way to go. Authors' reply

Alimentary pharmacology & therapeutics, 2022-03, Vol.55 (5), p.622-623

2022

Volltextzugriff (PDF)

Diagnostic and Treatment Algorithm of the Japanese Society of Hepatology: A Consensus-Based Practice Guideline

Oncology, 2010-07, Vol.78 (1), p.78-86

Izumi, Namiki

2010

Volltextzugriff (PDF)

Report of the 20th Nationwide follow‐up survey of primary liver cancer in Japan

Hepatology research, 2020-01, Vol.50 (1), p.15-46

2020

Volltextzugriff (PDF)

REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset

Journal of gastroenterology, 2020-01, Vol.55 (1), p.113-122

2020

Volltextzugriff (PDF)

A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation

Journal of gastroenterology, 2019-02, Vol.54 (2), p.171-181

2019

Volltextzugriff (PDF)

Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan

Journal of gastroenterology, 2019-06, Vol.54 (6), p.558-570

2019

Volltextzugriff (PDF)

Recent advances of radiofrequency ablation for early hepatocellular carcinoma

Journal of gastroenterology and hepatology, 2011-01, Vol.26 (s1), p.115-122

Izumi, Namiki

2011

Volltextzugriff (PDF)

Reply to Wang et al

Journal of viral hepatitis, 2021-09, Vol.28 (9), p.1335-1336

2021

Volltextzugriff (PDF)

Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)

Hepatology research, 2015-02, Vol.45 (2), p.n/a

2015

Volltextzugriff (PDF)

Efficacy of daclatasvir in hepatitis C virus

Expert review of anti-infective therapy, 2014-09, Vol.12 (9), p.1025-1031

Izumi, Namiki

2014

Volltextzugriff (PDF)

Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality

Alimentary pharmacology & therapeutics, 2022-02, Vol.55 (3), p.292-301

2022

Volltextzugriff (PDF)

Report of the 22nd nationwide follow‐up Survey of Primary Liver Cancer in Japan (2012–2013)

Hepatology research, 2022-01, Vol.52 (1), p.5-66

2022

Volltextzugriff (PDF)

Branched‐chain amino acids as pharmacological nutrients in chronic liver disease

Hepatology (Baltimore, Md.), 2011-09, Vol.54 (3), p.1063-1070

2011

Volltextzugriff (PDF)

Report of the 19th follow-up survey of primary liver cancer in Japan

Hepatology research, 2016-04, Vol.46 (5), p.372-390

2016

Volltextzugriff (PDF)

Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method

Hepatology research, 2018-09, Vol.48 (10), p.821-828

2018

Volltextzugriff (PDF)

A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma

Cancer science, 2020-10, Vol.111 (10), p.3759-3769

2020

Volltextzugriff (PDF)

Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases

Annals of Laboratory Medicine, 2021, 41(1), , pp.16-24

2021

Volltextzugriff (PDF)

Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients

Hepatology research, 2021-11, Vol.51 (11), p.1170-1171

2021

Volltextzugriff (PDF)

Report of the 21st Nationwide Follow‐up Survey of Primary Liver Cancer in Japan (2010–2011)

Hepatology research, 2021-04, Vol.51 (4), p.355-405

2021

Volltextzugriff (PDF)

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Liver cancer (Basel ), 2021-06, Vol.10 (3), p.181-223

2021

Volltextzugriff (PDF)

Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey

Journal of hepatology, 2013-04, Vol.58 (4), p.724-729

2013

Volltextzugriff (PDF)

1 – 25 von 804

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(703)
Mit Volltextzugriff
(747)

Publikationsform

Sprache

Englisch
(686)
Japanisch
(301)
Koreanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Clinical practice guidelines for hepatocellular carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC guidelines) 2019 update

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: A Japanese nationwide survey

Letter: association of laboratory indexes and magnetic resonance elastography‐associated liver stiffness with complications and mortality—authors' reply

Letter: predictive role of magnetic resonance elastography in chronic liver disease—still a long way to go. Authors' reply

Diagnostic and Treatment Algorithm of the Japanese Society of Hepatology: A Consensus-Based Practice Guideline

Report of the 20th Nationwide follow‐up survey of primary liver cancer in Japan

REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset

A randomized controlled trial of lusutrombopag in Japanese patients with chronic liver disease undergoing radiofrequency ablation

Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan

Recent advances of radiofrequency ablation for early hepatocellular carcinoma

Reply to Wang et al

Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines)

Efficacy of daclatasvir in hepatitis C virus

Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality

Report of the 22nd nationwide follow‐up Survey of Primary Liver Cancer in Japan (2012–2013)

Branched‐chain amino acids as pharmacological nutrients in chronic liver disease

Report of the 19th follow-up survey of primary liver cancer in Japan

Novel quantitative assessment system of liver steatosis using a newly developed attenuation measurement method

A randomized, double‐blind, placebo‐controlled, phase 3 study of tivantinib in Japanese patients with MET‐high hepatocellular carcinoma

Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases

Diagnostic accuracy of hepatocellular carcinoma risk prediction models during antiviral therapy in chronic hepatitis B patients

Report of the 21st Nationwide Follow‐up Survey of Primary Liver Cancer in Japan (2010–2011)

Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update

Comparison of resection and ablation for hepatocellular carcinoma: A cohort study based on a Japanese nationwide survey

Suchergebnisse filtern